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The global increase in the proportion of older population contributes to the increasing number of patients with 
renal insufficiency. This disorder particularly involves the old (age 70-75) and very old (over 80) population 
groups. The number of comorbidities is increasing and life expectancy reduced with aging. Cross-sectional 
analysis of ten-year survival showed a rate of 33.9% in patients treated at the Hemodialysis Center, 23.81% 
in transplanted patients and 19.35% in dialyzed patients. In patients having started hemodialysis (HD) at 
the age of ≥70, the mean survival was 20.27±18.62 months, in those that died 15.54±17.35 months, and in 
survivors 30.29±17.85 months. Among HD treated patients, 35% survived for up to one year, 18% for two 
years and 8% for ≥3 years. Karnofsky index was below 50% in all patients that survived, while the Malnutri-
tion Inflammation Score and Subjective Global Assessment indicated malnutrition. In Croatia, the number 
of HD patients is constantly increasing as the result of population aging, better, accessible and equal health 
care that prolongs life span, easier access to substitution methods, more accesses to the vascular system, 
development of the national transplant network and good immunosuppressive therapy. All this provides bio-
logical, economic and normative space for replacement therapy. Old age, comorbidities and poor nutritional 
status influence high mortality, poor functional status and impaired quality of life. Survival results correspond 
to reports in the literature.
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INTRODuCTION
There is rapid increase in the number of elderly patients 
in the world who need dialysis treatment. These reports 
are consistent from different countries of America, Can-
ada, Europe and Australia. The problems that accom-
pany old age are multiple(1). There are different attitudes 
to stratify age limits. There are various age group clas-
sifications, so that some propose young old age 60-69, 
middle old age 70-79 and very old age ≥80 years, where-
as others set the following limits: young old age 65-74, 
middle old age 75-84 and oldest old age >85 years. How-
ever, life span has extended and the increase in the eld-
erly population with all related comorbidities is inevita-
ble. End-stage renal disease has a much higher incidence 
in elderly than in young population and is constantly 
growing worldwide, either as a disease, comorbidity, 
or as a result of various states. This raises questions of 
physiology and pathophysiology of aging and changes 
in the glomerular filtration rate (GFR). Is there a clear 
stance on normal laboratory values  adjusted for age lim-
its? To what degree is GFR a physiological variant for a 
particular age? Does hemodialysis (HD) extend lifetime 
of very old people? The answers are not always precise. 
According to Singh et. al.(2), prognosis is often based 
on subjective assessment and should include the ability 
to detect patients with end-stage renal disease who will be 
treated with HD, professional teams for communication with 
such patients, as well as guidance with solid attitudes(3).
Elderly population is often exposed to doctor, family 
or guardian decisions that are against their wishes, 
either due to the lack of communication or lack of 
knowledge about the methods and procedures to be 
employed. Procedures can leave mental and physical 
consequences (suffering) in spite of being performed 
professionally, and these patients say, “if I knew what 
I had to go through, I would have never agreed to it”. 
Therefore, it is necessary to respect patient decisions, 
especially when we are aware that they may be close 
to the end of life and would rather choose pallia-
tive care than these procedures. The aforementioned 
author gives examples of giving up patients having 
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started dialysis in 25% of cases before their death in the 
uS population. The same source says that in one Cana-
dian study, 60% of patients complained of having started 
dialysis treatment, and half of them claimed they did so 
upon doctor persuasion(2). No matter what, we must not 
forget individual approach and have to respect the will of 
the patient when he wants to be subjected to any proce-
dures, including kidney transplantation.
PATIENTS
We performed retrograde analysis of 10-year survival 
in patients treated in dialysis unit. On cross-sectional 
analysis of all patients at the time of testing, we deter-
mined the types of access for dialysis according to age 
categories. Then we selected a group of patients aged 
≥70 at the time of their starting dialysis treatment. We 
recorded outcomes at 1, 2, 3, 4 and ≥5 years. In pa-
tients that survived 6 months after the end of monitor-
ing the Malnutrition Inflammation Score (MIS) and 
Karnofsky index were determined(4). Data were proc-
essed using standard statistical analysis. We examined 
a total of 77 patients from beginning of treatment, 70 
66.23% of men and 33.77% of women, 28.57% of them 
aged 70-75, 45.45% aged 76-80 and 25.97% aged ≥80. 
(Table 1)
Table 1
Patient distribution according to age and sex
RESuLTS
Retrograde analysis of ten-year survival of dialysis patients 
showed that 19.35% of all study patients (age range, 25-87 
years) were treated with dialysis for more than 6 months. 
There was a general trend of elderly patients prevailing on 
dialysis. The cross-sectional analysis of the test year at the 
Center showed that there were 31.76% of patients aged ≤60 
years and 49.23% of patient older than 71; 57.65% of them 
had AV fistula, 11.76% temporary catheter and 30.59% 
permanent catheter. When we selected patients older than 
70, there were 77 patients recorded in 5 years. Analysis of 
five-year survival in elderly patients showed the following 
mean survival rates: 20.27±18.62 months all, 15.54±17.35 
months in those that died, and 30.29±17.85 months in sur-
vivors (dialysis).
Table 2 shows outcomes according to age groups. It is inter-
esting to note how death rates changed with age, i.e. young-
er age was associated with lower mortality rate, whereas 
the highest death rate was recorded in the 76-80 age group.
There were 25 survivors, 14 (56%) male and 11 (44%) fe-
male patients, that started HD at age 70. After 6 months, 
MIS score 7 or more was observed in 10 (40%) patients. 
The mean MIS was 5.68±2.56, range 1-12. The mean 
Karnofsky score in patients that survived ≥6 months was 
50±12.91, range 30-80.
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Table 1. Patient distribution according to ag  and sex
  
 Age (yrs), n (%) Total 
N (%) 70-75 76-80 ≥80 
Male 14  (63.64) 22  (62.86) 15  (75.0)   51 (66.23) 
Female 8  (36.36) 13  (37.14)   5  (25.0)   26 (33.77) 
Total 22  (28.57) 35  (45.45)  20  (25.98) 77  (100) 
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Age (yrs), n (%) Total 
N (%) 70-75 76-80 ≥80 
Died 6 (11.75) 29 (56.86) 16 (31.37) 51 (66.23) 
Living (dialysis) 15 (62.5) 6 (25.0) 3 (12.5) 24 (31.17) 
Recovered   1 1 (1.3) 
Transplanted    0 
Other unit or 
modality change 
1   1 (1.3) 
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Table 3
Patient distribution according to survival and age group
DISCuSSION
Analysis of our data revealed the presence of very old 
population with a large number of associated comorbidi-
ties and a high degree of malnutrition according to MIS 
and Karnofsky score. In the Center, there were more than 
49.23% of elderly patients (older than 70), with a high rate 
of temporary or permanent central venous catheter (CVC) 
as access for dialysis (42.35%). Most of the patients that 
survived 1, 2, and 3 years were in the 76-80 age group, 
whereas none from the >80 age group survived for 4 or 5 
years. Elderly survivors have low ability of independent 
functioning (the mean Karnofsky score in those surviv-
ing ≥6 months was 50%) and poor nutritional status (MIS 
5.68). All this favors development of infection, new co-
morbidities, worsening of the already impaired quality of 
life, and uncertain prognosis. The question is whether all 
patients need dialysis treatment, in which context defini-
tive decision should be considered relative to the expected 
prognosis and especially respecting patient wish. Can we 
agree that in old age, low clearance without heart failure, 
hyperhydration, hyperkalemia, acidosis and uremic toxic-
ity with preserved diuresis should be observed because 
the planned approach may not be used or such interven-
tion could aggravate the patient condition? According 
to Glassock(2), decreased GFR in the elderly can be ex-
plained by anatomical changes in terms nephrosclerosis 
and decay of individual glomeruli. These morphological 
changes associated with significant albuminuria or pro-
teinuria are serious warning, regardless of age. Further-
more, GFR declines with age, depending individually 
on the presence of diabetes, hyperlipidemia, smoking, 
atherosclerosis, etc., along with primary renal disease 
which, if present, additionally worsens the condition. Re-
duction in clearance below 45-59 should not be considered 
as chronic kidney disease (CKD) without the presence of 
other signs of the disease(2). High age negatively affects 
outcome of patients on HD. In a study in patients aged 
>75, malnutrition had negative effect on overall survival, 
regardless of the dose of dialysis(5). Dialysis accesses are 
often the source of frustration and failure, especially with 
AV fistula. It is a pathomorphological substrate for poor 
outcome. It can be associated with traditional age related 
factors such as hypertension, dyslipidemia, diabetes, etc. 
In uremic inflammation, oxidative stress, uremic tox-
ins, damage to the endothelium, calcification of arterial 
media, vein damage, and eventually intimal hyperplasia 
cause AV fistula dysfunction.
While on the other side of the CVC, although the only way 
out, in most cases in very old population it often implies 
additional risks (infection, thrombosis), this approach is 
preferred by patients and sometimes by the staff to fa-
cilitate manipulation. CVC is much more frequently used 
in elderly as compared with younger patients on dialysis 
in Europe, Australia, North America, but rarely in Japan 
(less than 1%)(1). Of course, it should be viewed different-
ly in particular groups of the elderly, and AV fistula may 
be considered the first option; however, if it is not pos-
sible, then aretoriovenous graft (AVG) should be applied. 
Considering survival for the first 18 months, AVG may 
prove better than AV fistula(2). Transplantation should not 
be marginalized in elderly patients because it can prove 
either beneficial or a risk. Therefore, the choice of treat-
ment modality in these patients should be based on strict 
and thorough assessment. There is no specific age that 
would be considered a limit, since the overall condition 
is essential for transplantation rather than age. In the early 
postransplant period,  there is a high risk of death in this 
group of patients, but later it progressively diminishes and 
life expectancy with transplanted organ is longer6. We 
must not forget the frequent postransplant diseases these 
patients are prone to, i.e. diabetes, osteoporosis, infec-
tions, and malignancies. Transplantation is unquestion-
ably beneficial for some patients. There are still problems 
encountered in practice, related to very old patients with 
multiple complications and poor prognosis, such as refus-
ing or discontinuing dialysis after starting dialysis treat-
ment, as reported in the literature. These may refer to 
socioeconomic issues or legally defined procedures and 










Age (yrs), n (%) Total 
N (%) 70-75 76-80 ≥80 
<1 3 (8.57) 17 (48.57) 15 (42.86) 35 (45.45) 
<2 8 (44.45) 6 (33.34) 4 (22.21) 18 (23.38) 
<3 4 (50.0) 3 (37.5) 1 (12.5) 8 (10.39) 
<4 2 (25.0) 6 (75.0) 0 8 (10.39) 
≥5 5 (62.5) 3 (37.5) 0 8 (10.39) 
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Many nephrologists often meet with the treatment of old 
people because of the extended life expectancy. Somatic 
treatment is often very complex, requiring expertise and 
empathy. In order to make appropriate decisions and 
provide optimal treatment for the elderly with associated 
diseases, nephrologists should preferably be familiar 
with some basic psychological concepts of functioning 
of every human that are deeply subconscious and serve 
the patient to pass more easily through traumatic reality. 
These are also known as defense mechanisms.
When the patient is cooperative, everything is much 
easier; however, when he is negativistic for any reason, 
then psychiatric help is needed to eliminate the cause 
of negativism and if possible proceed with psychiatric 
treatment in such patients.
When both somatic and psychological or psychiatric 
resources have been exhausted, ethical dilemmas fre-
quently appear and are very complex. In case of pro-
foundly demented and dying patients, a physician will 
do everything to support patient survival, at least for 
some time. Occasionally, it will require patient family 
consent, and sometimes patient family will refuse it. 
In the complex treatment of elderly patients with many 
associated, complex diseases, it may sometimes be dif-
ficult to make the diagnosis, determine prognosis and 
imminent death. It is even more difficult to make any 
decisions that affect ethical domain, in addition to those 
we have been trained, i.e. help the patient until the last 
moment. In my opinion, it is necessary to work on the 
issue of our own decisions in a similar situation, and in 
accordance with current, healthy mental capacity make 
a decision and thus help their families and doctors, just 
as in case of organ donation.
Many times, we are faced with the duty of providing bad 
news to elderly patients, such as news about their disease 
and its prognosis, which can be rather stressful for both. 
It is even more difficult to make decisions that are of dif-
ferent ethical perspective than the one that all physicians 
know, i.e. help every patient until the very last moment. 
I believe that patients which are psychologically compe-
tent should make their own decisions in situations like 
these, i.e. decide whether they want to keep fighting or 
give up their battle.
The substitution treatment of elderly CKD patients 
should have a reasonable individual approach. There are 
no clear guidelines, as they are mostly vague and neu-
tral. For some patients, replacement procedures can be 
beneficial, and for the others harmful. Physicians should 
be trained to provide information about treatment op-
tions, taking care of life expectancy, favorable and detri-
mental effects of the procedures, and the patient wishes. 
The patient should be allowed to choose the modality of 
treatment, the type of access and enrolment in the trans-
plant list.
Aging is an integral part of the life cycle that is extend-
ed, resulting in accumulation of many factors that di-
rectly or indirectly influence GFR decline. Significant 
GFR reduction in combination with other factors for 
replacement therapy should be considered individually. 
The patient must be detected early, properly educated, 
and should be aware of all treatment modalities. Deci-
sions must be signed by the patient or guardian. The will 
and dignity of the person should be respected.
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SAŽETAK
POSEBNOST DIJALIZE u STARIH I VRLO STARIH BOLESNIKA – DILEME
D. KLARIć1, P. GRBIć PAVLOVIć i V. KLARIć
Opća bolnica Zadar, Odjel za dijalizu i
1Odjel za psihijatriju, Zadar, Hrvatska
U svijetu je ubrzan porast broja starijih bolesnika koji trebaju liječenje dijalizom. Ti se izvještaji poklapaju iz 
raznih zemalja. Problemi koje nosi starija dob su višestruki. Različiti su stavovi za stratifikaciju dobnih grani-
ca. Bilo kako bilo, dobne granice su produžene i porast starije populacije sa svim pratećim komorbiditetima je 
neizbježan. Kronična bubrežna bolest ima puno veću incidenciju u među starom negoli među mlađom popu-
lacijom i u stalnom je porastu u svijetu bilo kao bolest, komorbiditet ili posljedica raznih stanja. Ova činjenica 
nameće pitanja fiziologije i patofiziologije starenja i promjena u glomerularnoj filtraciji (GF). Ima li jasnih sta-
vova o normalnim laboratorijskim vrijednostima prilagođenim dobnoj granici? U kojem stupnju je GF fiziološ-
ka varijanta za konkretnu dob? Produžava li liječenje hemodijalizom životni vijek vrlo starih osoba? Odgovori 
nisu uvijek precizni. Stara populacija često je izložena odlukama liječnika, obitelji ili skrbnika mimo svoje 
želje, bilo zbog nedostatka komunikacije ili zbog nepoznavanja postupaka. Procedure mogu na bolesnika 
ostaviti psihičke i fizičke posljedice (patnje), bez obzira na to što su sve napravljene profesionalno, oni često 
kažu “da sam znao što me čeka, ne bih pristao”. Zbog toga je nužno poštivati odluku bolesnika. Analizom 
vlastitih podataka vidljiva je prisutnost veoma stare populacije s velikim brojem pridruženih komorbiditeta te 
visokim stupnjem pothranjenosti (MIS) i Karnofskyjeva skora. U Centru je više od 49,23% populacije starije 
od 70 godina, s velikom zastupljenošću privremenog ili trajnog centralnog venskog katetera kao pristupa za 
dijalizu (42,35%). Najviše preživjelih do 1, 2 i 3 godine bilo je u skupini od 76-80 godina, a u skupini starijih od 
80 godina nitko nije preživio 4 ili 5 godina. Kod preživjelih bolesnika visoke dobi sposobnost za samostalno 
funkcioniranje je veoma mala. Karnofskyjev zbir za preživjele 6 mjeseci i više bio je u prosjeku 50%.
Ključne riječi: stari bolesnici, dijaliza, preživljenje
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